Is stenting indicated for vertebral artery stenosis?

Vertebral Artery Stenting: Current Evidence and Recommendations

Vertebral artery stenting may be considered only for symptomatic extracranial vertebral stenosis in patients who continue to have recurrent posterior circulation TIAs or strokes despite optimal medical therapy, but it is not routinely recommended due to limited evidence of benefit. 1

Primary Treatment Approach

Optimal medical therapy is the first-line treatment for all patients with vertebral artery stenosis, regardless of stenosis severity or location. 1 This includes:

• Antiplatelet therapy (aspirin 81-325 mg daily, clopidogrel 75 mg daily, or aspirin plus extended-release dipyridamole) 1
• High-intensity statin therapy for cholesterol management 1
• Aggressive risk factor modification including blood pressure control, diabetes management, and smoking cessation 1

Evidence for Stenting

Extracranial Vertebral Stenosis

Stenting of extracranial vertebral stenosis can be performed with very low periprocedural complication rates (0-2%), making it technically feasible. 2, 3 However, the clinical benefit remains uncertain:

• The VIST trial showed no statistically significant difference in stroke prevention (hazard ratio 0.40,95% CI 0.14-1.13, p=0.08), though there was a trend toward benefit. 2, 4
• A pooled analysis of three trials (VIST, VAST, SAMMPRIS) involving 354 patients found no evidence of benefit for stenting overall (HR 0.81,95% CI 0.45-1.44). 5
• For extracranial stenosis specifically, the pooled HR was 0.63 (95% CI 0.27-1.46), suggesting possible benefit but lacking statistical significance. 5

The American Heart Association/American Stroke Association guidelines classify endovascular treatment as Class IIb, Level of Evidence C, meaning it "may be considered" but with weak supporting evidence. 1

Intracranial Vertebral Stenosis

Stenting of intracranial vertebral stenosis carries substantially higher periprocedural risk (15-22% stroke rate) and is NOT recommended. 2, 3 The evidence strongly favors medical management:

• Periprocedural complications are 8-15 times higher for intracranial versus extracranial stenting. 5, 2
• The SAMMPRIS trial demonstrated that intensive medical therapy was superior to stenting for intracranial stenosis. 3
• Pooled analysis showed no benefit for intracranial stenting (HR 1.06,95% CI 0.46-2.42). 5

Current Guideline Recommendations

The 2024 ESC Guidelines state that no clear benefit was shown for extracranial vertebral artery stenting in combined analysis of major trials. 6

The 2011 AHA/ASA Guidelines recommend:

• Class I, Level B: Optimal medical therapy for all patients with vertebral stenosis 1
• Class IIb, Level C: Endovascular or surgical treatment may be considered only when patients have recurrent symptoms despite optimal medical treatment 1

Clinical Decision Algorithm

1. All patients: Initiate optimal medical therapy immediately (antiplatelet, statin, risk factor control) 1

2. If symptoms persist despite 3-6 months of optimal medical therapy:

   • Confirm stenosis location (extracranial vs. intracranial) with CTA or MRA 7
   • For extracranial stenosis: Consider stenting in experienced centers with documented low complication rates, though benefit is unproven 1, 5
   • For intracranial stenosis: Continue intensive medical therapy; do NOT pursue stenting 3

3. Surgical revascularization (vertebral endarterectomy, transposition) may be considered for extracranial disease but carries 10-20% mortality and requires highly specialized expertise. 8

Critical Caveats

• The evidence base is weak: All major trials were underpowered and failed to reach recruitment targets. 5, 2, 4
• High rates of non-confirmation of stenosis occurred in stented groups, suggesting diagnostic uncertainty. 4
• Periprocedural risk varies dramatically by location: Extracranial stenting is relatively safe, but intracranial stenting carries unacceptable risk. 5, 2
• Medical therapy has improved substantially since older trials were designed, potentially reducing any benefit from stenting. 3

Bottom Line

Medical therapy remains the standard of care for vertebral artery stenosis. Stenting should only be considered for carefully selected patients with extracranial stenosis who have recurrent symptoms despite documented optimal medical management, and only when performed by experienced operators in centers with proven low complication rates. 1, 6 Larger randomized trials are needed before stenting can be routinely recommended. 5, 2